Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
Price Target
Average
20.86%
Revenue Forecast
Estimate
46.48%
EBIT
Estimate
--152.37%
Net Income
Estimate
76.53%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Alnylam Pharmaceuticals, Inc.
Wall Street analysts predict an average 1-year price target for ALNY of $298 , with forecasts ranging from
a
low of
$234 to a high of $400 .
ALNY Lowest Price Target
Wall Street Target
234 USD
-4.98%
ALNY Average Price Target
Wall Street Target
298 USD
20.86%
ALNY Highest Price Target
Wall Street Target
400 USD
62.42%
REVENUE FORECAST
Revenue Forecast Chart ALNY
EBIT FORECAST
EBIT Forecast Chart ALNY
NET INCOME FORECAST
Net Income Chart ALNY